The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

Apr. 30, 2015
Applicants:

Fundació Institut D'investigació Biomèdica DE Bellvitge (Idibell), Hospitalet de Llobregat, Barcelona, ES;

Institut Català D'oncologia (Ico), Barcelona, ES;

Inventors:

Ramon Alemany Bonastre, Castelldefels-Barcelona, ES;

Luis Alfonso Rojas Expósito, Sabadell, ES;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/315 (2006.01); C12N 7/00 (2006.01); A61K 35/761 (2015.01); C07K 14/005 (2006.01); C07K 14/075 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/315 (2013.01); A61K 35/761 (2013.01); C07K 14/005 (2013.01); C07K 14/075 (2013.01); C12N 7/00 (2013.01); A61K 48/00 (2013.01); C07K 2319/00 (2013.01); C07K 2319/10 (2013.01); C07K 2319/31 (2013.01); C07K 2319/70 (2013.01); C12N 2710/10321 (2013.01); C12N 2710/10322 (2013.01); C12N 2710/10332 (2013.01); C12N 2710/10334 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/10371 (2013.01);
Abstract

The invention relates to a recombinant adenovirus comprising an albumin-binding moiety on the outer surface of the adenoviral hexon protein, pharmaceutical compositions containing it and its medical use. Particularly, the invention relates to an oncolytic adenovirus comprising a sequence encoding an albumin-binding moiety inserted in the hypervariable region 1 (HVR1) of the hexon protein coding sequence and its use in the prevention and/or treatment of cancer.


Find Patent Forward Citations

Loading…